(2024) 11:e2404073
7 July 2026 7 min Polynucleotide under-eye treatment: what it fixes and what it doesn't What polynucleotide under-eye treatment can realistically fix, what it can't, and how to tell whether it suits your under-eye concern
The brand Zepbound is FDA-approved for chronic weight management in adults with obesity or who are overweight with a related health condition
Seth Gold, Louisianas Medicaid director, said at the legislative hearing on Boudreauxs bill the annual treatment for one patient costs around $16,000, and around 145,000 Medicaid enrollees would meet the requirements laid out in the bill to receive the medication
Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews
This innovative treatment aims to redefine our approach to obesity management and sits at the centre of a broader, long-term strategy: local clinical research, corporate partnerships, community toolkits, internal initiatives and public platforms such as Truth About Weight. Professor Dr